Hendrik Schulze‐Koops

18.0k citations
290 papers · 9.8k · 3 hit papers · h-index 50

Impact in

  • Rheumatology top 0.1%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Immunology top 0.5%
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Rheumatoid Arthritis Research and Therapies 80
    • Systemic Lupus Erythematosus Research 27
    • Spondyloarthritis Studies and Treatments 23
    • T-cell and B-cell Immunology 39
    • Immune Cell Function and Interaction 24

Hendrik Schulze‐Koops

274 papers receiving 9.5k citations

Hendrik Schulze‐Koops's Hit Papers

Trial of Tocilizumab in Giant-Cell Arteritis 2017 · 926 citations
9260+4+9Years since publication250500750

Peers

Hendrik Schulze‐Koops
Comparison fields: 5 of 138
  • Rheumatology 3.3k
  • Immunology 2.8k
  • Hematology 1.1k
  • Genetics 568
  • Physiology 237
Replace Naoyuki Kamatani with:
Naoyuki Kamatani Japan
Marco Gattorno Italy
Xavier Bossuyt Belgium
Nobuyuki Miyasaka Japan
Raphaela T. Goldbach‐Mansky United States
Robert I. Fox United States
Robert P. Kimberly United States
Pnina Langevitz Israel
Javier J. Martin Spain
Ellen M. Gravallese United States
Hendrik Schulze‐Koops relative to Naoyuki Kamatani Japan Naoyuki Kamatani's profile →
Citations per field
00.5×2×3.4×
Naoyuki Kamatani · 1×
Citations per year

Countries citing papers authored by Hendrik Schulze‐Koops

Since Specialization
Citations

This map shows the geographic impact of Hendrik Schulze‐Koops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Schulze‐Koops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Schulze‐Koops more than expected).

Fields of papers citing papers by Hendrik Schulze‐Koops

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Schulze‐Koops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Schulze‐Koops. The network helps show where Hendrik Schulze‐Koops may publish in the future.

Co-authors

The 25 scholars most cited alongside Hendrik Schulze‐Koops, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hendrik Schulze‐Koops Line = papers co-authored together Hendrik Schulze‐Koops links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 290 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trial of Tocilizumab in Giant-Cell Arteritis
Hit paper breakdown →
2017926
2
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Hit paper breakdown →
2012839
3 2010384
4 2007318
5
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
Hit paper breakdown →
2013286
6 1999277
7
The central role of T cells in rheumatoid arthritis.
2008243
8 2018240
9 2001232
10 1995227
11 2020179
12 2014168
13 2017140
14 2021138
15 2005133
16 1995123
17 199895
18 202091
19 201191
20 199289

About Hendrik Schulze‐Koops

Hendrik Schulze‐Koops is a scholar working on Rheumatology, Immunology, Hematology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 290 papers that have together received 9.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (80 papers), T-cell and B-cell Immunology (39 papers), Autoimmune and Inflammatory Disorders Research (34 papers), Vasculitis and related conditions (31 papers), Systemic Lupus Erythematosus Research (27 papers), Immune Cell Function and Interaction (24 papers), Spondyloarthritis Studies and Treatments (23 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). The work is most often cited by research in Rheumatology (3.3k citations), Immunology (2.8k citations), Hematology (1.1k citations), Genetics (568 citations) and Physiology (237 citations). Hendrik Schulze‐Koops has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Alla Skapenko, Peter E. Lipsky, Joachim Robert Kalden, Jan Leipe, Martin Aringer, Laurie S. Davis, John J. Cush, Andrew P. Cope, Georg Schett and Claudia Dechant. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, RMD Open, Journal of Clinical Medicine and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact